Company Search:
Advanced Search
Sponsored Links
Protek PAO Company Snapshot
Protek PAO operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protek PAO with three other pharmaceutical manufacturers in Europe: UCB Sa of Belgium (2015 sales of 3.88 billion Euro [US$4.19 billion] of which 100% was Biopharmacy), Stada Arzneimittel AG of Germany (2.12 billion Euro [US$2.29 billion] of which 58% was Generics), and Lonza Group AG which is based in Switzerland (3.80 billion Swiss Francs [US$3.83 billion] of which 57% was Specialty Ingredients).

Sales Analysis. During the year ended December of 2015, sales at Protek PAO were 195.31 billion Russian Rubles (US$3.38 billion). This is an increase of 24.4% versus 2014, when the company's sales were 156.95 billion Russian Rubles. This was the fifth consecutive year of sales increases at Protek PAO (and since 2010, sales have increased a total of 96%). Sales of Distribution saw an increase of 24.7% in 2015, from 127.46 billion Russian Rubles to 158.94 billion Russian Rubles.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Protek PAO
  Stock Performance Chart for Protek PAO
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 106.40
(Figures in Russian Rubles)
1 Week 2.8%   13 Weeks -5.7%  
4 Weeks 8.0%   52 Weeks 54.2%  
Protek PAO Key Data:
  Ticker: PRTK Country: Russian Federation
  Exchanges: RTS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 195,308,866,000
(Year Ending Jan 2016).
Employees: 11,800
  Currency: Russian Rubles Market Cap: 56,087,999,985
  Fiscal Yr Ends: December Shares Outstanding: 527,142,857
  Share Type: Closely Held Shares: 465,000,621
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.